Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FE9AU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,035
Award facts
- Contract value 100% obligated
- $18,034.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,034.80 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on December 12, 2025, with an ultimate completion date of December 15, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion master contract running through December 2026 that serves as the primary pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of medications and medical supplies to federal military and veteran healthcare systems through the Defense Logistics Agency. The company's federal contract portfolio demonstrates extensive capability in delivering specialty pharmaceuticals, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. The DLA is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, which may involve additional contractors alongside AmerisourceBergen's continued participation.
Quick answers
Who was awarded contract SPE2DR26FE9AU?
SPE2DR26FE9AU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FE9AU worth?
The government has obligated $18,035 on SPE2DR26FE9AU.
Is contract SPE2DR26FE9AU an order under another contract?
Yes. SPE2DR26FE9AU is a delivery order under SPE2DR25D3104, an indefinite delivery contract.
Was contract SPE2DR26FE9AU competed?
The extent of competition for SPE2DR26FE9AU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award